CVE-2026-42208 exploited within 36 hours of disclosure, exposing LiteLLM credentials, risking cloud account compromise.
Ozempic injection is approved by the Food and Drug Administration (FDA) for certain uses in people with type 2 diabetes. It can be prescribed off-label to help with weight loss, but it’s not approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results